Tumor Suppressor Genes in Human Cancer

ISBN-13: 9781617371981 / Angielski / Miękka / 2010 / 386 str.

Ed. David E. Fisher

Opis

David Fisher, MD, PhD, and an authoritative panel of academic, cutting-edge researchers review and summarize the current state of the field. Describing the broad roles of tumor suppressors from a perspective based in molecular biology and genetics, the authors detail the major suppressors and the pathways they regulate, including cell cycle progression, stress responses, apoptosis, and responses to DNA damage. Leading-edge and forward-looking, Tumor Suppressor Genes in Human Cancer illuminates what is currently known of tumor suppressor genes and their regulation, work that is already beginning to revolutionize cancer target elucidation, drug discovery, and treatment design.

Recenzje

"...brings together a panel of experts in the field of cancer biology, with almost half of the authors from Harvard Medical School. ...describes he role of tumor suppressor genes in human cancer. It details a current view of these important genes and highlights clinically relevant aspects of the strides made in the field of tumor suppressor biology. ...The book is well organized with most chapters having figures and tables to clarify the points made in the text. It is well referenced....This book provides readable, yet thorough, coverage of the field of tumor suppressor biology." -Doody's Health Sciences Book Review Journal

Spis treści

Part I. Analysis and Clinical Implications of Tumor Suppressor Genes. Animal Models for Tumor Suppressor Genes, Jordan A. Kreidberg and Thomas A. Natoli. Viral Oncoproteins as Probes for Tumor Suppressor Function, Srikmar P. Chellappan. Tumor Suppressors in Metastasis, Taoufik Ouatas, Melanie T. Hartsough, and Patricia S. Steeg. Apoptosis: Machinery of Cell Death in Development and Cancer, Jinyan Du and David E. Fisher. Drug Discovery in Oncology, Alex Matter. Part II. Tumor Suppressor Pathways. Retinoblastoma Protein in Growth Control and Differentiation, Lilia Stepanova and J. Wade Harper. p53 Tumor Suppressor Protein, Margaret Ashcroft and Karen H. Vousden. p16 Tumor Suppressor, Alexander Kamb and Ken McCormack. DNA Mismatch Repair in Tumor Suppression, Guo-Min Li, Scott McCulloch, and Liya Gu. PTEN: Regulator of Phosphoinositide 3-Kinase Signal Transduction, Jen Jen Yeh and William R. Sellers. Neurofibromatoses, André Bernards and Andrea I. McClatchey. Von Hippel-Lindau Disease: Clinical and Molecular Aspects, Othon Iliopoulos and William G. Kaelin Jr. Wilms' Tumor: A Developmental Anomaly, Aswin L. Menke and Nick D. Hastie. The Fanconi Anemia Pathway and Cancer Susceptibility, Yanan Kuang, Irene Garcia-Higuera, Eric Nisbet-Brown, Anna Savoia, and Alan D. D'Andrea. Index.

Blurb

While the war against cancer has seen great advances in our understanding of cell proliferation and its regulation at the molecular level, the translation of this knowledge into effective therapies has lagged well behind. In Tumor Suppressor Genes in Human Cancer, David Fisher, MD, PhD, and an authoritative panel of academic, cutting-edge researchers review and summarize the current state of the field. Describing the broad roles of tumor suppressors from a perspective based in molecular biology and genetics, the authors detail the major suppressors and the pathways they regulate, including cell cycle progression, stress responses, apoptosis, and responses to DNA damage. Additional coverage is accorded animal models, viral oncoproteins as probes, and cancer metastasis. An extensive chapter on cancer drug discovery is provided to help integrate the new molecular oncology with technologies which fuel the pragmatic search for improved cancer therapeutics.
Leading-edge and forward-looking, Tumor Suppressor Genes in Human Cancer illuminates what is currently known of tumor suppressor genes and their regulation, work that is already beginning to revolutionize cancer target elucidation, drug discovery, and treatment design.